Does FIBRINOGEN HUMAN\THROMBIN HUMAN Cause Product use in unapproved indication? 95 Reports in FDA Database

Q: Does FIBRINOGEN HUMAN\THROMBIN HUMAN cause Product use in unapproved indication?

95 reports of Product use in unapproved indication have been filed with the FDA for FIBRINOGEN HUMAN\THROMBIN HUMAN, representing 9.5% of all FIBRINOGEN HUMAN\THROMBIN HUMAN adverse event reports.

Q: How dangerous is Product use in unapproved indication from FIBRINOGEN HUMAN\THROMBIN HUMAN?

Of 95 reports, 3 (3.2%) resulted in death and 10 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Product use in unapproved indication have been filed in association with FIBRINOGEN HUMAN\THROMBIN HUMAN. This represents 9.5% of all adverse event reports for FIBRINOGEN HUMAN\THROMBIN HUMAN.

Reports of Product use in unapproved indication with FIBRINOGEN HUMAN\THROMBIN HUMAN

9.5%

of all FIBRINOGEN HUMAN\THROMBIN HUMAN reports

Deaths

Hospitalizations

How Dangerous Is Product use in unapproved indication From FIBRINOGEN HUMAN\THROMBIN HUMAN?

Of the 95 reports, 3 (3.2%) resulted in death, 10 (10.5%) required hospitalization, and 2 (2.1%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FIBRINOGEN HUMAN\THROMBIN HUMAN. However, 95 reports have been filed with the FAERS database.

What Other Side Effects Does FIBRINOGEN HUMAN\THROMBIN HUMAN Cause?

Off label use (225) Drug ineffective (132) Cerebrospinal fluid leakage (57) Haemorrhage (50) Seroma (49) Drug ineffective for unapproved indication (42) Product physical consistency issue (31) Wound infection (29) Post procedural complication (26) Haematoma (23)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which FIBRINOGEN HUMAN\THROMBIN HUMAN Alternatives Have Lower Product use in unapproved indication Risk?

FIBRINOGEN HUMAN\THROMBIN HUMAN vs FIDAXOMICIN FIBRINOGEN HUMAN\THROMBIN HUMAN vs FILGOTINIB FIBRINOGEN HUMAN\THROMBIN HUMAN vs FILGRASTIM FIBRINOGEN HUMAN\THROMBIN HUMAN vs FILGRASTIM-AAFI FIBRINOGEN HUMAN\THROMBIN HUMAN vs FILGRASTIM-SNDZ

FIBRINOGEN HUMAN\THROMBIN HUMAN Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication FIBRINOGEN HUMAN\THROMBIN HUMAN Demographics